With alarm. â¡ Without alarm. After ________minutes. I get up. ______. Minutes. ______. Minutes. ______. Minutes. Once in a while I take a nap during the day.
Additional data file 2: List of the selected genes included in the human d-siRNA signaling library. UniquelD Gene. NP#. NM#. Conserved Domains. H01-0001 ...
Mar 13, 2016 - number. Dutch Trial Registration. NTR5697. Date of registration in primary .... a statement to better clarify how we will assure equal groups on.
... Stelfox T, Bagshaw S,. Choong K, Lamontagne F et al: Critically ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA 2009, 302(17):1872-1879.
Unknown. Unknown. C. Ahearn. BAH. Unknown. J.T. Carlton et al. Unknown ... Specimen. Eucidaris metularia (Lamarck,. 1816). Caenopedina mirabilis.
Figure S2: Performance comparisons for FindPath, ExPA and efmtools for run time per output and memory use in function of size of input and size of output.
7.0-7.6. 7.6-8.2. 8.2-9.0. >9.0 mean lactate (mmol/L) quintiles n u m b e. r o. f p atien ts ... Mean insulin dose in IU/h during the first 24 hours after admission to the ...
MammaPrint predictor. IV. Statistical comparison for concordance of differential gene expression patterns among six breast cancer subtypes between KFSYSCC ...
International Classification of Diseases, 10th Revision. (ICD-10) codes. Tomás J. Aragón, MD, DrPH. December 28, 2007. Our cause of death categories were ...
Acacia etbaica Schweinf. Fabaceae. Hamaressa. EL167. Inability to walk properly /Dereba. L. R. F/D. Cdr. Acacia mellifera (Vahl ) .... Breonadia salicina (Vahl).
Boscia salicifolia Oliv. Capparidaceae. Qalqalchi qalada EL111. Diarrhoea /Tuma. L. RB. D. Cdr. Boscia senegalensis Lam. ex Poir. Capparidaceae. Qalqalcha.
If the person decides to seek professional help, the first aider should encourage them to take a support person to their appointment. 1. As far as possible, the first ...
1.78 1.32-2.41. Charlson Comorbidity Index. Median (25% perc./75% perc./range). 1 (1/2/12). 1 (1/1/9). NA NA. Charlson Comorbidity Index (categories). 0.
Additional file 2 Flowchart study population:
Detailed information on characteristics and co-medication of cases and controls for each outcome at the index date: Characteristics and co-medication of cases with bone-related conditions and matched controls at the index date No. of Cases (%) No. of Controls (%) Crude OR 95% CI (N=8,907) (N=35,445) Male 2,752 (30.9) 10,956 (30.9) NA NA 6,155 (69.1) 24,489 (69.1) NA NA Female Age 18-39 2,321 (26.1) 9,263 (26.1) NA NA 40-59 2,713 (30.5) 10,858 (30.6) NA NA 60-79 2,947 (33.1) 11,781 (33.2) NA NA ≥80 926 (10.4) 3,543 (10.0) NA NA Smoking status non 4,495 (50.5) 18,672 (52.7) 1.00 reference current 1,438 (16.1) 5,020 (14.2) 1.20 1.12-1.29 ex 2,767 (31.1) 10,935 (30.9) 1.05 0.99-1.10 unknown 207 (2.3) 818 (2.3) 1.06 0.90-1.25 Alcohol consumption (average units per week) none 4,231 (47.5) 16,714 (47.2) 1.00 reference
